Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Curcumin (with Piperine/Liposomal) | Omega-3 (EPA/DHA) | |
|---|---|---|
| Category | Supplements | Supplements |
| Standard Dose | 500-1000mg curcuminoids daily (enhanced bioavailability form) | 2-4g combined EPA/DHA daily (targeting 2:1 EPA:DHA ratio for inflammation; 1:1 for cognitive) |
| Timing | With meals containing fat. Piperine enhances absorption 2000% but also affects drug metabolism. | With meals containing fat for absorption. Split dose AM/PM. |
| Cycle Duration | ongoing | ongoing |
| Evidence Level | strong_human | strong_human |
Curcumin modulates over 100 molecular targets. Primary mechanisms include direct inhibition of NF-kB nuclear translocation (master inflammatory transcription factor), suppression of COX-2 and iNOS expression, inhibition of STAT3 and AP-1 signaling, and activation of Nrf2-ARE pathway upregulating Phase II detoxification enzymes (glutathione S-transferase, heme oxygenase-1). It also inhibits mTOR signaling and modulates epigenetic enzymes (HATs, HDACs, DNMTs).
500-1000mg curcuminoids daily (enhanced bioavailability form)
With meals containing fat. Piperine enhances absorption 2000% but also affects drug metabolism.
ongoing
EPA and DHA incorporate into cell membrane phospholipids, modulating membrane fluidity and lipid raft signaling. EPA competitively inhibits arachidonic acid conversion via COX-2 and 5-LOX, reducing pro-inflammatory eicosanoids (PGE2, LTB4) while generating anti-inflammatory resolvins and protectins. DHA is critical for neuronal membrane integrity, modulating BDNF expression and synaptic plasticity via Nrf2 and NF-kB pathways.
2-4g combined EPA/DHA daily (targeting 2:1 EPA:DHA ratio for inflammation; 1:1 for cognitive)
With meals containing fat for absorption. Split dose AM/PM.
ongoing
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →